Page last updated: 2024-08-23

substance p and Craniofacial Pain Syndromes

substance p has been researched along with Craniofacial Pain Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austermann, K; Göbel, H; Heinze, A; Heinze-Kuhn, K1
Kaeser, HE1

Reviews

2 review(s) available for substance p and Craniofacial Pain Syndromes

ArticleYear
[Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Der Nervenarzt, 2001, Volume: 72, Issue:4

    Topics: Analgesics, Non-Narcotic; Botulinum Toxins, Type A; Clinical Trials as Topic; Cluster Headache; Dystonic Disorders; Facial Neuralgia; Germany; Headache Disorders; Humans; Migraine Disorders; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Neuromuscular Agents; Practice Guidelines as Topic; Substance P

2001
[So-called atypical facial neuralgias].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1989, Sep-19, Volume: 78, Issue:38

    Topics: Carotid Arteries; Cluster Headache; Enkephalins; Facial Neuralgia; Ganglia, Parasympathetic; Ganglia, Sympathetic; Humans; Substance P; Trigeminal Neuralgia

1989